Latest News
Latest News moreAmoyDx Collaborates with AstraZeneca to Develop a HER2 Companion Diagnostic for Lung Cancer in China
We are thrilled to announce that AmoyDx reaches a new collaboration agreement with AstraZeneca. Under this agreement, the AmoyDx® Essential NGS panel will be used as a companion diagnostic of ENHERTU® to identify HER2 (ERBB2) mutations in patients with no
AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib RET fusion positive NSCLC
The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the AmoyDx® Pan Lung Cancer PCR Panel (the “AmoyDx PLC Panel”) as a companion diagnostic for RET fusion-positive non-small cell lung cancer (“NSCLC”), for selpercatinib capsules 40 mg
AmoyDx will be attending the 2023 AACR Annual Meeting in Florida
Say hello to us at booth 1220 and learn more about our companion diagnostic solutions.
Career Opportunities - The Field Application Scientist
The Field Application Scientist is responsible for system usage training at customer sites while providing PCR/NGS experimental design, data analysis, logistical, and troubleshooting support for LATAM.
- 15 /Aug AmoyDx Collaborates with AstraZeneca to Develop a HER2 Companion Diagnostic for Lung Cancer in China
- 27 /Mar AmoyDx® Pan Lung Cancer PCR Panel Approved in Japan as a Companion Diagnostic for selpercatinib RET fusion positive NSCLC
- 24 /Mar AmoyDx will be attending the 2023 AACR Annual Meeting in Florida
- 25 /Nov Career Opportunities - The Field Application Scientist
New Products
new product release-
- 01
- 02
- 03
- 04
-
- 01
- 02
- 03
- 04
-
- 01
- 02
- 03
- 04
-
- 01
- 02
- 03
- 04
New Products
new product release-
NGS
-
PCR
-
FISH
-
Extraction

- Customer Service
- FAQS
- DOWNLOAD





ESMO Asia
https://www.esmo.org/meetings/esmo-asia-congress-2022
December 2-4, 2022AMP
https://www.amp.org/events/amp-events-calendar/calendar/amp-2022-annual-meeting-expo/
November 3-5, 2022-
Stock Info
Stock info -
24.88 +%0.81Stock code:300685 Real-time data
- View details
